Xintela AB

Xintela AB

Biotechnology Research Lund, Skåne Län, Se 18 employees
Employees
18
Contacts
2
Emails
2

Xintela AB Overview

Headquarters
Lund, Skåne Län, Se
Phone Number
Available in AeroLeads
Website
xintela.se
Industry
Biotechnology Research
Employees
18
Founded
2009
Funding
939.8K
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Xintela AB

Xintela develops medical products in stem cell therapy and targeted cancer therapy based on the Company's cell surface marker integrin α10β1 which is found on mesenchymal stem cells and on certain aggressive cancer cells. The stem cell marker is used to select and quality-assure the patent-protected stem cell product XSTEM®, which is in clinical development for treatment of knee osteoarthritis and difficult-to-heal leg ulcers. The company produces XSTEM for the clinical studies in its GMP-approved manufacturing facility. In cancer therapy, which is run by the wholly owned subsidiary Targinta AB, therapeutic antibodies, targeting integrin α10β1 (First-in-Class) are being developed for the treatment of triple-negative breast cancer and the brain tumor glioblastoma.

Xintela AB Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage

Xintela AB Org Chart

Sample employees and titles
Name Title Contact
Tina Uvebrant Research Scientist at Xintela Ab
Email
Dr. Achim Simons Surgeon - Founding Partner and CEO of Bluerock Healthcare Advisors - Investor - Advisory Board Member
View
Lars Hedbys
View
Gunnar Telhammar Entrepreneur & Investor
Email

Employees by Management Level

Individual contributor 4 profiles
Executive 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 0

Xintela AB Tech Stack

Data / AI 1 profile
Engineering 1 profile

Compare Similar Companies to Xintela AB